Our goal is to provide our clients with an effective combination of market-insights, launch experience, and strategic support to elevate them to a leadership position in the emerging markets race.
New York City, NY (PRWEB) October 22, 2013
CBPartners, one of the world’s leading authorities on strategic issues related to healthcare, is excited to welcome Sandeep Duttagupta, Ph.D., to lead the emerging markets business across all five practices.
With a rich history of successful launches with Pfizer emerging markets, Dr. Duttagupta provides clients with a strong set of real-world experiences and thought leadership to maximise the value of pharmaceutical products around the world. Prior to joining CBPartners, Dr. Duttagupta spent two decades with Pfizer, where he most recently ran the pricing and market access functions within the emerging markets. In this role, he led the development of the company's strategic emerging markets pricing framework, devised multiple innovative access initiatives involving local banks and NGOs, developed multiple second-brand strategies to minimise international reference pricing risk and maintain market share, and implemented partnerships with Ministries of Health around the world.
“CBPartners combines real-world emerging markets experience with excellent engagement leadership, and an unparalleled global network through GHAB, the Global Health Advisory Board,” Dr. Duttagupta explains. “Our goal is to provide our clients with an effective combination of market-insights, launch experience, and strategic support to elevate them to a leadership position in the emerging markets race.”
Cyrus Chowdhury, CBPartners Chief Executive Officer, states “Dr. Duttagupta’s experience in the emerging markets with multinationals, domestic manufacturers, industry trade-groups, and local stakeholders raises CBPartners’ emerging markets capabilities to new heights. His expertise will be used to infuse our existing capabilities with new commercial insights and top-tier methodologies.”
Dr. Duttagupta will lead the emerging markets business from CBPartners’ New York City office, but will execute his client responsibilities globally.
CBPartners is a leading global strategy consulting firm focusing on healthcare issues for a variety of clients, including biopharmaceutical companies, medical device companies and government health authorities. Headquartered in New York City, CBPartners maintains a continuous throughput of local market intelligence updates from advisors throughout 73 markets. CBPartners provides expertise through five practice areas including Pricing and Market Access, Value Demonstration, Portfolio Optimisation, Commercial Planning, and Government Policy Advisory.
To reach Dr. Duttagupta, please contact him at sandeep(dot)duttagupta(at)cbpartners(dot)com or +1 917 951 2652. To learn more about CBPartners, please visit http://www.cbpartners.com, or follow CBPartners on Twitter: http://www.twitter.com/CBPartners.